Not Signed In -
Epoetin Alfa Injection |
EPO; Epogen; Erythropoietin; Procrit |
erythropoietin Identifiers Symbol(s) EPO Entrez 2056 OMIM 133170 RefSeq NM_000799 UniProt P01588 PDB [1] Other data EC number [2] Locus Chr. 7 q21 Erythropoietin (IPA pronunciation: [ɪˌɹɪθ.ɹoˈpo.ɪ.tɪn], alternative pronunciations: [ɪˌrɪθroʊˈpɔɪtn, əˌrɪθroʊ-, əˌriθroʊ-]) or EPO is a glycoprotein hormone that is a cytokine for erythrocyte (red blood cell) precursors in the bone marrow. Also called hematopoietin or hemopoietin. It is pro ...
Wikipedia - [full article]
Epoetin Alfa Injection Clinical Trials
- Darbepoetin Alfa Compared With Epoetin alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
ClinicalTrials.gov Identifier: NCT00046982 - Active, not recruiting
Fatigue; Anemia; unspecified adult solid tumor, protocol specific
- Darbepoetin alfa Compared With Epoetin alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
ClinicalTrials.gov Identifier: NCT00070382 - Active, not recruiting
adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
- D.O.S.E. Registry
ClinicalTrials.gov Identifier: NCT00212862 - Active, not recruiting
Cancer; Anemia; Epoetin Alfa; Darbepoetin Alfa
- Radiation Therapy With or Without Epoetin alfa in Treating Patients With Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00017277 - Active, not recruiting
Oral Cancer; Throat Cancer
- A Study of Four Dosing Regimens of PROCRIT® (Epoetin Alfa) in Patients with Chronic Kidney Disease
ClinicalTrials.gov Identifier: NCT00212875 - Active, not recruiting
Kidney Diseases; Injections, Subcutaneous; Anemia
- Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00052221 - Active, not recruiting
unspecified adult solid tumor, protocol specific; Fatigue
- Epoetin alfa With or Without Filgrastim Compared With Blood Transfusions in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003138 - Active, not recruiting
Anemia; Myelodysplastic Syndromes; Quality of Life
- A Study to Investigate the Neuroprotective Effect of PROCRIT® (Epoetin Alfa) Versus Placebo in Ovarian Cancer Patients Who Develop Chemotherapy-Induced Peripheral Neuropathy
ClinicalTrials.gov Identifier: NCT00267007 - Active, not recruiting
Peripheral Neuropathy, Chemotherapy-Induced; Ovarian Cancer
- Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia
ClinicalTrials.gov Identifier: NCT00315484 - Active, not recruiting
Chemotherapy; Anemia
- Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue
ClinicalTrials.gov Identifier: NCT00004914 - Active, not recruiting
Anemia; unspecified adult solid tumor, protocol specific; Fatigue
- Epoetin alfa in Treating Anemia in Patients With Solid Tumors
ClinicalTrials.gov Identifier: NCT00058331 - Active, not recruiting
adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
- Epoetin alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
ClinicalTrials.gov Identifier: NCT00003341 - Active, not recruiting
Lymphoma; Leukemia; Multiple Myeloma
- Cost-Effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia
ClinicalTrials.gov Identifier: NCT00264108 - Recruiting
Neoplasms; Anemia
- Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer
ClinicalTrials.gov Identifier: NCT00482716 - Recruiting
Anemia; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific
- Epoetin alfa in Treating Cancer-Related Anemia in Patients With Non-Myeloid Cancer Who Are Not Currently Receiving Chemotherapy or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00090935 - Active, not recruiting
adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
- Radiation Therapy With or Without Epoetin alfa in Anemic Patients With Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00004917 - Active, not recruiting
Anemia; Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
- Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
ClinicalTrials.gov Identifier: NCT00416624 - Recruiting
Anemia; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific
- A Study to Determine the Safety of Epoetin Alfa and Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients After Major Orthopedic Surgery.
ClinicalTrials.gov Identifier: NCT00270036 - Completed
Anemia; Blood Transfusion; Orthopedic Procedures
- Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
recurrent prostate cancer; Anemia; Fatigue
- An Efficacy and Safety Study of PROCRIT® (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks
ClinicalTrials.gov Identifier: NCT00338416 - Completed
Epoetin Alfa; Chemotherapy; Anemia; Cancer
- Amifostine With or Without Epoetin alfa in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003681 - Active, not recruiting
Refractory Anemia; Previously Treated Myelodysplastic Syndrome; Anemia; secondary myelodysplastic syndrome; ...
- Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
ClinicalTrials.gov Identifier: NCT00017004 - Active, not recruiting
Anemia; Cervical Cancer; Drug Toxicity; Quality of Life; radiation toxicity
- A Randomized, Double-Blind, Equivalence Study of the Efficacy of Epoetin Alfa Manufactured by Deep Tank Bioreactor Technology and Epoetin Alfa Manufactured by Roller-Bottle Technology for the Treatment of Anemia in Patients with Chronic Kidney Disease (CK
ClinicalTrials.gov Identifier: NCT00146224 - Completed
Nephrology
- The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study)
ClinicalTrials.gov Identifier: NCT00401869 - Active, not recruiting
Anemia
- Treatment of Chronic Anemia With Epoetin Alfa in Elderly
ClinicalTrials.gov Identifier: NCT00337441 - Active, not recruiting
Anemia
- A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
ClinicalTrials.gov Identifier: NCT00422513 - Active, not recruiting
Anemia
- Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer
ClinicalTrials.gov Identifier: NCT00294203 - Recruiting
Anemia
- Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer
ClinicalTrials.gov Identifier: NCT00258440 - Active, not recruiting
Anemia; Fatigue; Unspecified Adult Solid Tumor, Protocol Specific
- A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing Preoperative Chemoradiation Followed by Surgery
ClinicalTrials.gov Identifier: NCT00036400 - Completed
Stomach Neoplasms; Rectal Neoplasms
- Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa
ClinicalTrials.gov Identifier: NCT00210626 - Recruiting
Anemia
- An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease
ClinicalTrials.gov Identifier: NCT00440557 - Active, not recruiting
Kidney Diseases; Anemia
- Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer
ClinicalTrials.gov Identifier: NCT00255749 - Active, not recruiting
Anemia; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific
- A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)
ClinicalTrials.gov Identifier: NCT00307814 - Active, not recruiting
Anemia; Chronic Renal Insufficiency
- EPO Deep Tank in CKD Subjects
ClinicalTrials.gov Identifier: NCT00156962 - Active, not recruiting
Chronic Kidney Disease
- The Safety and Effectiveness of PROCRIT (Epoetin Alfa) in Reducing the Number of Blood Transfusions Required by Patients Undergoing Elective Major Abdominal and/or Pelvic Surgery
ClinicalTrials.gov Identifier: NCT00350519 - Recruiting
Hemostasis, Surgical
- A Study to Assess the Effectiveness of PROCRIT® (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00246298 - Terminated
HIV; Anemia
- Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial
ClinicalTrials.gov Identifier: NCT00322413 - Completed
End Stage Renal Disease; Renal Anemia; Regular Dialysis Treatment
- Idiopathic Anemia of Aging (IAA)
ClinicalTrials.gov Identifier: NCT00104169 - Active, not recruiting
Anemia; Aging
- A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00306267 - Terminated
Epoetin Alfa; Anemia; Cancer
- A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy
ClinicalTrials.gov Identifier: NCT00270283 - Active, not recruiting
Acquired Immunodeficiency Syndrome; Anemia
- An Efficacy and Safety Study of Epoetin Alfa for the Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease
ClinicalTrials.gov Identifier: NCT00440466 - Recruiting
Kidney Diseases; Anemia
- A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy
ClinicalTrials.gov Identifier: NCT00270270 - Active, not recruiting
Acquired Immunodeficiency Syndrome; Anemia
- Peginterferon Alfa-2a Plus Ribavirin and Epoetin β in HIV-Infected Patients Coinfected With Hepatitis C Virus Not Responding to Previous Treatment Regimens
ClinicalTrials.gov Identifier: NCT00470210 - Recruiting
Hepatitis C; HIV Infections
- Study for the Treatment of Anemia in Patients with Non-Myeloid Malignancies Receiving Multicycle Chemotherapy.
ClinicalTrials.gov Identifier: NCT00148421 - Completed
Anemia
- A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-Term Care Facilities.
ClinicalTrials.gov Identifier: NCT00337935 - Recruiting
Renal Failure , Chronic; Anemia
- Epoetin alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00003600 - Completed
Lung Cancer; Leukemia; Lymphoma; Breast Cancer; Multiple Myeloma
- Epoetin Alfa for HIV-Associated Neuropathy Trial
ClinicalTrials.gov Identifier: NCT00528593 - Recruiting
HIV Infections; Neuropathy
- Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00400686 - Recruiting
Anemia; Multiple Myeloma and Plasma Cell Neoplasm
- Effect of Procrit(Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation
ClinicalTrials.gov Identifier: NCT00425126 - Recruiting
Delayed Graft Function
- Phase II Study of Arginine Butyrate With or Without Epoetin alfa in Patients With Thalassemia Intermedia
ClinicalTrials.gov Identifier: NCT00006136 - Completed
beta-Thalassemia
- A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov Identifier: NCT00446602 - Not yet recruiting
Myelodysplastic Syndromes; Anemia
- A Study to Collect Information About Risk Factors in the Development of a Rare Form of Anemia (Pure Red Cell Aplasia; PRCA) and Antibodies to Erythropoietin From Patients With Kidney Disease Treated With Epoetin Alfa
ClinicalTrials.gov Identifier: NCT00211068 - Active, not recruiting
Red-Cell Aplasia, Pure; Kidney Failure, Chronic
- A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Subjects With Metastatic Breast Cancer Receiving Standard Chemotherapy
ClinicalTrials.gov Identifier: NCT00338286 - Recruiting
Neoplasm Metastasis; Breast Cancer
- Luveris®(Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (LH <1.2 IU/L)
ClinicalTrials.gov Identifier: NCT00328926 - Recruiting
Hypogonadotropic Hypogonadism
- A study of switching from maintenance treatment with intravenous epoetin alfa to maintenance treatment with intravenous Ro 50-3821 in hemodialysis patients with chronic renal anemia
ClinicalTrials.gov Identifier: NCT00048035 - Completed
Renal Anemia
- Thalidomide and Epoetin alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00053001 - Completed
de novo myelodysplastic syndromes; secondary myelodysplastic syndromes; previously treated myelodysplastic syndromes; Anemia; ...
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
ClinicalTrials.gov Identifier: NCT00402428 - Active, not recruiting
Chronic Hepatitis C
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
ClinicalTrials.gov Identifier: NCT00411385 - Active, not recruiting
Chronic Hepatitis C
- Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT®) in Critically Ill Patients.
ClinicalTrials.gov Identifier: NCT00210756 - Completed
Critical Illness; Anemia
- A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery.
ClinicalTrials.gov Identifier: NCT00270179 - Completed
Anemia
- Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Living Donor Liver Transplantation
ClinicalTrials.gov Identifier: NCT00135798 - Recruiting
Hepatitis C
- An Efficacy and Safety Study for Epoetin Alfa (PROCRIT®) in Cancer Patients Not Receiving Chemotherapy or Radiation
ClinicalTrials.gov Identifier: NCT00210587 - Completed
Neoplasms; Anemia
- The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease
ClinicalTrials.gov Identifier: NCT00446576 - Completed
Anemia
- TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
Ovarian Neoplasms
- Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00210600 - Completed
Anemia
- A Safety and Efficacy Study for Epoetin Alfa in Pre-Dialysis Subjects.
ClinicalTrials.gov Identifier: NCT00364260 - Completed
Left Ventricular Hypertrophy; Anemia; Kidney Failure
- Open-Label Extension Safety Study of PROCRIT in Patients with Anemia of Chronic Disease Due to Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00123149 - Not yet recruiting
Rheumatoid Arthritis; Anemia
- A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00216541 - Completed
Neoplasms; Anemia
- Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00005787 - Active, not recruiting
Lymphocytic Lymphoma; Myeloid Lymphoma; Neutropenia
- Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy
ClinicalTrials.gov Identifier: NCT00224068 - Completed
Anemia
- Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00049348 - Active, not recruiting
adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
- Trial of Peg-Interferon Plus Epoetin-Alfa for Treatment of Chronic Hepatitis C Virus Infection
ClinicalTrials.gov Identifier: NCT00248339 - Completed
Hepatitis C
- Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00014222 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
- A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-Transfusion During and After Scheduled Joint Surgery.
ClinicalTrials.gov Identifier: NCT00270062 - Completed
Anemia
- PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00388336 - Completed
Anemia; Neoplasms
- Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT®) in the Treatment of Anemia.
ClinicalTrials.gov Identifier: NCT00210743 - Completed
Kidney Diseases; Anemia
- Combination Chemotherapy Plus Interferon alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
ClinicalTrials.gov Identifier: NCT00004039 - Active, not recruiting
Lymphoma
- Reduction of Immunosuppression Plus Interferon alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
ClinicalTrials.gov Identifier: NCT00002657 - Active, not recruiting
Lymphoma; Multiple Myeloma
- Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00524407 - Completed
Cancer; Chemotherapy; Anemia
- Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00002504 - Active, not recruiting
Lymphoma; Leukemia
- Interferon Alfa in Treating Children With HIV-Related Cancer
ClinicalTrials.gov Identifier: NCT00002621 - Active, not recruiting
Leukemia; Lymphoma
- A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer
ClinicalTrials.gov Identifier: NCT00269984 - Completed
Anemia
- A Study of the Safety and Efficacy of Long-Term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients
ClinicalTrials.gov Identifier: NCT00261521 - Completed
Kidney Failure, Chronic; Anemia
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy
ClinicalTrials.gov Identifier: NCT00266617 - Completed
Anemia; Neoplasms
- A Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys) plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C
ClinicalTrials.gov Identifier: NCT00087633 - Active, not recruiting
Hepatitis C
- Epoetin Alfa in Treating Fatigue in Patients Receiving Palliative Care for Advanced Cancer
ClinicalTrials.gov Identifier: NCT00563719 - Completed
Fatigue; Unspecified Adult Solid Tumor, Protocol Specific
- Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People
ClinicalTrials.gov Identifier: NCT00078442 - Active, not recruiting
HIV Infections
- A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-Containing Chemotherapy
ClinicalTrials.gov Identifier: NCT00283465 - Completed
Anemia; Neoplasm
- Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00022386 - Completed
stage I breast cancer; stage IIIB breast cancer; Anemia; stage IIIA breast cancer; Fatigue; stage II breast cancer; Quality of Life
- A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00211133 - Completed
Breast Neoplasms; Anemia; Quality of Life
- A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients with Hepatitis C
ClinicalTrials.gov Identifier: NCT00118768 - Active, not recruiting
Chronic Hepatitis C
- Zidovudine Levels in HIV Infected Patients Being Treated for HCV
ClinicalTrials.gov Identifier: NCT00059358 - Active, not recruiting
HIV Infections; Hepatitis C
- Vaccine Therapy Compared With Interferon alfa in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00003715 - Active, not recruiting
stage III melanoma
- A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.
ClinicalTrials.gov Identifier: NCT00413101 - Active, not recruiting
Anemia
- Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)
ClinicalTrials.gov Identifier: NCT00091910 - Completed
Anemia
- Interleukin-12 Followed by Interferon alfa in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00003451 - Active, not recruiting
Cancer
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-Containing Chemotherapy Drug
ClinicalTrials.gov Identifier: NCT00269997 - Completed
Neoplasms; Anemia
- Cisplatin, Interferon alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00003263 - Active, not recruiting
localized malignant mesothelioma
- A Study of Subjects with Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated with Platinum Plus Etoposide Chemotherapy with Or Without Darbepoetin Alfa
ClinicalTrials.gov Identifier: NCT00119613 - Active, not recruiting
Small Cell Lung Cancer
- COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
ClinicalTrials.gov Identifier: NCT00377481 - Completed
Anemia
Resources
- EPO (Drug Digest)
- Epoetin Alfa Injection (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
